Small T Oncoprotein of Merkel Cell Polyomavirus Attenuates Cisplatin-Induced Apoptosis and Enhances E1, E6/E7, MMP-1, and Ki-67 Expression in HeLa Cervical Cancer Cells
Open Access
- 9 March 2025
- journal article
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 15 (1) , 194-205
Abstract
Purpose: Cervical cancer (CxCa), is mainly caused by high-risk human papillomaviruses (hrHPV), which disrupt the regulation of p53 and pRb, leading to uncontrolled cell growth and cancer progression. Co-infection with human polyomaviruses like MCPyV has been observed in some HPV-positive cases, suggesting a potential combined effect on tumor development. Cisplatin is commonly used for advanced CxCa, but resistance, often due to p53 disruption, remains a significant challenge. challenge. This study investigates if MCPyV sT oncoprotein, together with HPV-18 oncoproteins, affects the transcription of key genes, influencing cell proliferation and cisplatin resistance in CxCa. Methods: The sT gene was cloned into the pCMV6 vector and introduced into E. coli DH5α cells. HeLa cells were transfected with pCMV6-sT using Lipofectamine 3000. Transfection efficiency was assessed using fluorescence microscopy and flow cytometry. Protein expression was analyzed by SDS-PAGE and Western blotting. Cytotoxicity was measured with the MTT assay, gene expression was analyzed by RT-qPCR, Ki-67 staining was performed on cell blocks, and cisplatin-induced effects on cell proliferation and apoptosis were examined. Results: Cytotoxicity assays showed a significant increase in cell viability at 0.2 μg of sT plasmid after 72 hours (13.76%, P < 0.05). MCPyV sT expression significantly upregulated the mRNA levels of E1 (4.22-fold), E6/E7 (3.80-fold), and MMP1 (6-fold) (P < 0.001). Increased Ki-67 positivity, indicated enhanced cell proliferation. Additionally, sT expression reduced cisplatin-induced apoptosis, with fewer apoptotic cells observed in the sT + cisplatin group compared to the cisplatin-only group (25.9% vs. 38.3%, P < 0.05). Conclusion: The simultaneous presence of MCPyV sT and HPV oncoproteins enhances resistance to cisplatin-induced apoptosis in cervical cancer cells, necessitating further investigation into viral oncoprotein interactions to overcome therapeutic resistance.Keywords
This publication has 69 references indexed in Scilit:
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000
- Expression of topoisomerase II and Ki‐67 in cervical carcinoma — clinicopathological study using immunohistochemistryAPMIS, 2000
- Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: Repression ofE6/E7-oncogene expression and induction of apoptosisInternational Journal of Cancer, 1996
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993
- Modulation of the human papillomavirus type 16 induced transformation and transcription by deletion of loci on the short arm of human chromosome 11 can be mimicked by SV40 small tVirology, 1992
- The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.Proceedings of the National Academy of Sciences, 1991
- Modulation of HPV18 and BPV1 transcription in human keratinocytes by simian virus 40 large T antigen and adenovirus type 5 E1A antigenJournal of Cellular Biochemistry, 1990
- Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigensJournal of Virology, 1987
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970